Drug Profile
Omzotirome - Torrent Pharmaceuticals
Alternative Names: T2-mimetic; TRC-150094Latest Information Update: 22 Mar 2022
Price :
$50
*
At a glance
- Originator Torrent Pharmaceuticals
- Class Antihyperglycaemics; Antihypertensives; Indenes; Obesity therapies; Peptidomimetics; Propionic acids; Pyrazoles
- Mechanism of Action Thyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Diabetes mellitus; Dyslipidaemias; Hypertension
- No development reported Metabolic syndrome
Most Recent Events
- 22 Mar 2022 TRC 150094 is still in phase III trials for Diabetes mellitus, Dyslipidaemias and Hypertension (Adjunctive treatment) in India, Philippines and Brazil (PO) (Torrent Pharmaceuticals pipeline, March 2022) (NCT03254446)
- 22 Mar 2022 No development reported - Phase-III for Diabetes mellitus (Adjunctive treatment) in Thailand, Sri Lanka (PO)
- 22 Mar 2022 No development reported - Phase-III for Dyslipidaemias (Adjunctive treatment) in Sri Lanka, Thailand (PO)